Advanced search
Publication Cover
Leukemia & Lymphoma Volume 35, 1999 - Issue 5-6
Submit an article Journal homepage
17
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Improvement of Quality of Life after Splenectomy in an HTLV-I Carrier with T-Cell Prolymphocytic Leukemia

Rika Sakai Department of Hematology and Chemotherapy, Kanagawa Cancer Center, Japan
,
Atsuo Maruta Department of Hematology and Chemotherapy, Kanagawa Cancer Center, Japan
,
Naoto Tomita First Department of Internal Medicine, Urafune Hospital Yokohama City University School of Medicine, Japan
,
Jun Taguchi First Department of Internal Medicine, Yokohama City University School of Medicine, Yokahama-shi 241–0815Japan
,
Shin Fujisawa First Department of Internal Medicine, Yokohama City University School of Medicine, Yokahama-shi 241–0815Japan
,
Koji Ogawa First Department of Internal Medicine, Yokohama City University School of Medicine, Yokahama-shi 241–0815Japan
,
Shigeki Motomura First Department of Internal Medicine, Urafune Hospital Yokohama City University School of Medicine, Japan
,
Fumio Kodama Department of Hematology and Chemotherapy, Kanagawa Cancer Center, Japan
,
Hiroshi Mohri First Department of Internal Medicine, Yokohama City University School of Medicine, Yokahama-shi 241–0815Japan
&
Yoshiaki Ishigatsubo First Department of Internal Medicine, Yokohama City University School of Medicine, Yokahama-shi 241–0815Japan
 show all
Pages 607-611 | Published online: 30 Mar 2010

References

  • Matutes E., Brito-Babapulle V., Swansbury J., Ellis J., Morilla R., Dearden C., Sempere A., Catovsky D. Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia. Blood 1991; 78: 3269–3274
  • Matutes E., Garcia T. J., O'Brien M., Catovsky D. The morphological spectrum of T-prolymphocytic leukemia. Br. J. Haematol. 1986; 64: 111–124
  • Mercieca J., Matutes E., Dearden C., MacLennan K., Catovsky D. The role of pentostatin in the treatment of T-cell malignacies: Analysis of response rate in 145 patients according to disease subtype. J. Clin. Oncol 1994; 12: 2588–259
  • Pawson R., Dyer M. J. S., Barge R., Matutes E., Thornton P. D., Emmett E., Kluin-Nelemans J. C., Fibbe W. E., Willemze R., Catovsky D. Treatment of T-cell prolymphocytic leukemia with human CD52 antibody. J. Clin. Oncol. 1997; 15: 2667–2672
  • Tokudome S., Maeda Y., Fukada K., Teshima D., Asakura T., Sueoka E., Motomura Y., Kusumoto Y., Imamura Y., Kiyokawa T., Ikeda M., Tokunaga O. Follow-up of asymptomatic HTLV-I carriers among blood donors in Kyushu, Japan. Cancer Causes Control 1991; 2: 75–78
  • Asou N., Kumagai X., Uekihara S., Ishii M., Sato M., Sakai K., Nishimura H., Yamaguchi K., Takatsuki K. HTLV-1 seroprevalence in patients with malignancy. Cancer 1986; 58: 903–907
  • Miyazaki K., Yamaguchi K., Tohya T., Ohba T., Takatsuki K., Okamura H. Human-T-cell leukemia virus type I infection as an oncogenic and prognostic risk factor in cervical and vaginal carcinoma. Obstet. Gynecol. 1991; 77: 107–110
  • Tokioka T., Shimamoto Y., Funai N., Nagumo F., Motoyoshi K., Tadano J., Yamaguchi M. Coexistence of acute monoblastic leukemia and adult T-cell leukemia: possible association with HTLV-I infection in both cases?. Leukemia & Lymphoma 1992; 8: 147–155
  • Kawachi Y., Watanabe A., Sakamoto Y., Abe T., Uchida T., Sacho M., Mori M., Setsu K. Acute myeloblasts leukemia associated with an intermediate state between the healthy carrier state and adult T-cell leukemia. Leukemia & Lymphoma 1995; 16: 505–509
  • Taylor A. M. R., Metcalfe J. A., Thick J., Mak Y.-F. Leukemia and lymphoma in ataxia telangiectagia. Blood 1996; 87: 423–438
  • Narducci M. G., Virgilio L., Isobe M., Stoppacciaro A., Elli R., Fiorilli M., Carbonari M., Antonelli A., Chessa L., Croce C. M., Russo G. TCL1 oncogene activation in preleukemic T cells from a case of ataxia-telangiectasia. Blood 1995; 86: 2538–2364
  • Katsuki T., Katsuki K., Imai J., Hinuma Y. Immune suppression in healthy carriers of adult T-cell leukemia retorovirus (HTLV-I): impairment of T-cell control of Epstein-Barr virus-infected B-cells. Jpn. J. Cancer Res. 1987; 78: 639–642
  • Tachibana N., Okayama A., Ishizaki J., Yokota T., Shishime E., Murai K., Shioiri S., Tsuda K., Essex M., Mueller N. Suppression of tuberculin skin reaction in healthy HTLV-I carriers from Japan. Int. J. Cancer 1988; 42: 829–831

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.